Scott K. Howell

2.6k total citations
33 papers, 2.1k citations indexed

About

Scott K. Howell is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Scott K. Howell has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Clinical Biochemistry, 13 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Molecular Biology. Recurrent topics in Scott K. Howell's work include Advanced Glycation End Products research (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Natural Antidiabetic Agents Studies (6 papers). Scott K. Howell is often cited by papers focused on Advanced Glycation End Products research (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Natural Antidiabetic Agents Studies (6 papers). Scott K. Howell collaborates with scholars based in United States, Canada and France. Scott K. Howell's co-authors include Paul J. Beisswenger, Benjamin S. Szwergold, Michael Mauer, Sundeep Lal, Roya Babaei‐Jadidi, Paul J. Thornalley, Robert G. Nelson, Nazeer Ahmed, Keith Drummond and Kenneth E. Smith and has published in prestigious journals such as Diabetes Care, Diabetes and Analytical Biochemistry.

In The Last Decade

Scott K. Howell

33 papers receiving 2.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Scott K. Howell 1.3k 837 549 478 307 33 2.1k
Kevin J. Wells‐Knecht 1.4k 1.1× 724 0.9× 630 1.1× 496 1.0× 313 1.0× 34 2.3k
Roya Babaei‐Jadidi 1.3k 1.1× 804 1.0× 1.2k 2.2× 648 1.4× 455 1.5× 37 3.2k
Mingzhan Xue 969 0.8× 429 0.5× 784 1.4× 421 0.9× 236 0.8× 39 1.9k
Naila Ahmed 2.3k 1.8× 997 1.2× 895 1.6× 876 1.8× 634 2.1× 25 3.1k
Mahtab U. Ahmed 1.4k 1.1× 607 0.7× 562 1.0× 540 1.1× 325 1.1× 7 1.9k
Samuel Rahbar 790 0.6× 785 0.9× 425 0.8× 338 0.7× 163 0.5× 32 1.8k
Paul J. Beisswenger 2.4k 1.9× 1.7k 2.0× 921 1.7× 857 1.8× 530 1.7× 62 4.0k
Kazuharu Ienaga 519 0.4× 271 0.3× 457 0.8× 314 0.7× 116 0.4× 71 1.5k
Charles L. Bisgaier 1.3k 1.1× 932 1.1× 1.4k 2.6× 517 1.1× 76 0.2× 57 4.4k
Klaus M. Biemel 647 0.5× 376 0.4× 401 0.7× 212 0.4× 168 0.5× 20 1.4k

Countries citing papers authored by Scott K. Howell

Since Specialization
Citations

This map shows the geographic impact of Scott K. Howell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott K. Howell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott K. Howell more than expected).

Fields of papers citing papers by Scott K. Howell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott K. Howell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott K. Howell. The network helps show where Scott K. Howell may publish in the future.

Co-authorship network of co-authors of Scott K. Howell

This figure shows the co-authorship network connecting the top 25 collaborators of Scott K. Howell. A scholar is included among the top collaborators of Scott K. Howell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott K. Howell. Scott K. Howell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez, Katherine, Carlee Moser, Judith S. Currier, et al.. (2021). Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus Infection. Open Forum Infectious Diseases. 8(10). ofab423–ofab423. 3 indexed citations
2.
Saremi, Aramesh, Scott K. Howell, Dawn C. Schwenke, et al.. (2017). Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study. Diabetes Care. 40(4). 591–598. 72 indexed citations
3.
Saulnier, Pierre‐Jean, Kevin M. Wheelock, Scott K. Howell, et al.. (2016). Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes. Diabetes. 65(12). 3744–3753. 70 indexed citations
4.
Beisswenger, Paul J., Scott K. Howell, Greg Russell, et al.. (2013). Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparation. Amino Acids. 46(2). 311–319. 31 indexed citations
5.
Beisswenger, Paul J., Scott K. Howell, Gregory B. Russell, et al.. (2013). Early Progression of Diabetic Nephropathy Correlates With Methylglyoxal-Derived Advanced Glycation End Products. Diabetes Care. 36(10). 3234–3239. 116 indexed citations
6.
Sakharova, Olga V., James Dziura, Geralyn Spollett, et al.. (2012). Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with Type 2 diabetes uncontrolled by oral agents. Journal of Diabetes and its Complications. 26(4). 333–338. 8 indexed citations
7.
Beisswenger, Paul J., Scott K. Howell, Todd A. MacKenzie, et al.. (2011). Two Fluorescent Wavelengths, 440 ex /520 em nm and 370 ex /440 em nm, Reflect Advanced Glycation and Oxidation End Products in Human Skin Without Diabetes. Diabetes Technology & Therapeutics. 14(3). 285–292. 43 indexed citations
8.
Szwergold, Benjamin S., Scott K. Howell, & Paul J. Beisswenger. (2005). Transglycation—A Potential New Mechanism for Deglycation of Schiff's Bases. Annals of the New York Academy of Sciences. 1043(1). 845–864. 23 indexed citations
9.
Howell, Scott K., et al.. (2005). Methylglyoxal Can Modify GAPDH Activity and Structure. Annals of the New York Academy of Sciences. 1043(1). 135–145. 86 indexed citations
10.
Ahmed, Nazeer, Roya Babaei‐Jadidi, Scott K. Howell, Paul J. Beisswenger, & Paul J. Thornalley. (2005). Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetologia. 48(8). 1590–1603. 190 indexed citations
11.
Beisswenger, Paul J., Scott K. Howell, Kenneth E. Smith, & Benjamin S. Szwergold. (2003). Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1637(1). 98–106. 109 indexed citations
12.
Szwergold, Benjamin S., Scott K. Howell, & Paul J. Beisswenger. (2002). Nonenzymatic glycation/enzymatic deglycation: a novel hypothesis on the etiology of diabetic complications. International Congress Series. 1245. 143–152. 12 indexed citations
13.
Szwergold, Benjamin S., Scott K. Howell, & Paul J. Beisswenger. (2001). Human Fructosamine-3-Kinase. Diabetes. 50(9). 2139–2147. 150 indexed citations
14.
Beisswenger, Paul J., et al.. (2001). α-Dicarbonyls Increase in the Postprandial Period and Reflect the Degree of Hyperglycemia. Diabetes Care. 24(4). 726–732. 145 indexed citations
15.
Beisswenger, Paul J., et al.. (1999). Metformin reduces systemic methylglyoxal levels in type 2 diabetes.. Diabetes. 48(1). 198–202. 363 indexed citations
16.
Howell, Scott K., et al.. (1998). Improving the Specific Gravity Adjustment Method for Assessing Urinary Concentrations of Toxic Substances. American Industrial Hygiene Association Journal. 59(6). 375–380. 27 indexed citations
17.
Sinclair, Jacqueline F., et al.. (1993). Toxicity of paracetamol in cultured chick hepatocytes treated with methotrexate. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 228(5-6). 289–298. 10 indexed citations
18.
Howell, Scott K., et al.. (1989). Daunorubicin-induced mammary tumors in the rat. European Journal of Cancer and Clinical Oncology. 25(11). 1549–1554. 3 indexed citations
19.
Howell, Scott K., Charles W. Haidle, & Yeu‐Ming Wang. (1986). Daunorubicin-induced DNA lesions in isolated rat hepatocytes and mammary epithelial cells. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 868(4). 254–261. 4 indexed citations
20.
Sinclair, Jacqueline F., et al.. (1986). Induction of 5-aminolaevulinate synthase by two- to five-carbon alcohols in cultured chick-embryo hepatocytes. Relationship to induction of cytochrome P-450. Biochemical Journal. 234(2). 405–411. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin J. Wells‐Knecht Breakdown of academic impact, for papers by Roya Babaei‐Jadidi Breakdown of academic impact, for papers by Mingzhan Xue Breakdown of academic impact, for papers by Naila Ahmed Breakdown of academic impact, for papers by Mahtab U. Ahmed Breakdown of academic impact, for papers by Samuel Rahbar Breakdown of academic impact, for papers by Paul J. Beisswenger Breakdown of academic impact, for papers by Kazuharu Ienaga Breakdown of academic impact, for papers by Charles L. Bisgaier Breakdown of academic impact, for papers by Klaus M. Biemel
Rankless by CCL
2026